Juvenescence Limited, a  life science and biotech company developing therapies to increase healthy human longevity, raised $50 million in its Series A financing. Founded in 2016 by Jim Mellon, Dr Greg Bailey, Dr Declan Doogan, Anthony Chow, and Alexander Pickett, the company creates, partners with,